(AVPT) Avepoint - Overview
Stock: Platform, License, Support, Maintenance
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 49.3% |
| Relative Tail Risk | -8.37% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.11 |
| Alpha | -62.58 |
| Character TTM | |
|---|---|
| Beta | 1.118 |
| Beta Downside | 1.064 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.17% |
| CAGR/Max DD | 0.61 |
Description: AVPT Avepoint January 10, 2026
AvePoint, Inc. (NASDAQ:AVPT) delivers a cloud-native data-management platform that integrates with major SaaS providers such as Microsoft 365, Salesforce, Google Workspace, AWS, Box, and Dropbox. The company’s Platform-as-a-Service (PaaS) offering helps enterprise customers address data-governance, migration, and backup challenges while providing licensing, support, and maintenance services. Founded in 2001, AvePoint is headquartered in Jersey City, New Jersey, and operates across North America, Europe, the Middle East, Africa, and the Asia-Pacific.
Key recent metrics (FY 2023) include $388 million in total revenue, a 13 % year-over-year increase driven primarily by a 28 % rise in subscription ARR, and a gross margin of roughly 84 %. The business benefits from macro-level drivers such as the accelerated shift to multi-cloud environments and tightening data-privacy regulations (e.g., GDPR, CCPA), which raise enterprise spending on data-governance solutions. The Application Software sub-industry continues to see strong demand, with the broader SaaS market projected to grow at a CAGR of ~12 % through 2028, supporting AvePoint’s growth outlook.
For a deeper quantitative assessment, you may find ValueRay’s analyst framework useful for benchmarking AvePoint’s valuation against peers.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 1.97m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -4.60 > 1.0 |
| NWC/Revenue: 85.24% < 20% (prev 46.32%; Δ 38.92% < -1%) |
| CFO/TA 0.12 > 3% & CFO 88.4m > Net Income 1.97m |
| Net Debt (-460.3m) to EBITDA (34.0m): -13.52 < 3 |
| Current Ratio: 2.37 > 1.5 & < 3 |
| Outstanding Shares: last quarter (232.9m) vs 12m ago 26.61% < -2% |
| Gross Margin: 74.51% > 18% (prev 0.75%; Δ 7376 % > 0.5%) |
| Asset Turnover: 65.31% > 50% (prev 68.24%; Δ -2.93% > 0%) |
| Interest Coverage Ratio: 93.78 > 6 (EBITDA TTM 34.0m / Interest Expense TTM 299.0k) |
Altman Z'' -0.88
| A: 0.45 (Total Current Assets 580.7m - Total Current Liabilities 244.9m) / Total Assets 743.5m |
| B: -0.69 (Retained Earnings -510.9m / Total Assets 743.5m) |
| C: 0.05 (EBIT TTM 28.0m / Avg Total Assets 603.2m) |
| D: -1.82 (Book Value of Equity -504.1m / Total Liabilities 276.7m) |
| Altman-Z'' Score: -0.88 = CCC |
Beneish M -3.13
| DSRI: 0.91 (Receivables 90.9m/80.0m, Revenue 394.0m/315.9m) |
| GMI: 1.00 (GM 74.51% / 74.61%) |
| AQI: 0.84 (AQ_t 0.19 / AQ_t-1 0.22) |
| SGI: 1.25 (Revenue 394.0m / 315.9m) |
| TATA: -0.12 (NI 1.97m - CFO 88.4m) / TA 743.5m) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of AVPT shares?
Over the past week, the price has changed by -9.11%, over one month by -22.62%, over three months by -23.60% and over the past year by -44.86%.
Is AVPT a buy, sell or hold?
- StrongBuy: 5
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AVPT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19 | 79.9% |
| Analysts Target Price | 19 | 79.9% |
| ValueRay Target Price | 11.3 | 7.2% |
AVPT Fundamental Data Overview February 03, 2026
P/B = 5.5102
Revenue TTM = 394.0m USD
EBIT TTM = 28.0m USD
EBITDA TTM = 34.0m USD
Long Term Debt = 11.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 6.62m USD (from shortTermDebt, last fiscal year)
Debt = 11.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -460.3m USD (from netDebt column, last quarter)
Enterprise Value = 2.05b USD (2.51b + Debt 11.3m - CCE 471.6m)
Interest Coverage Ratio = 93.78 (Ebit TTM 28.0m / Interest Expense TTM 299.0k)
EV/FCF = 24.63x (Enterprise Value 2.05b / FCF TTM 83.2m)
FCF Yield = 4.06% (FCF TTM 83.2m / Enterprise Value 2.05b)
FCF Margin = 21.12% (FCF TTM 83.2m / Revenue TTM 394.0m)
Net Margin = 0.50% (Net Income TTM 1.97m / Revenue TTM 394.0m)
Gross Margin = 74.51% ((Revenue TTM 394.0m - Cost of Revenue TTM 100.4m) / Revenue TTM)
Gross Margin QoQ = 74.35% (prev 74.04%)
Tobins Q-Ratio = 2.76 (Enterprise Value 2.05b / Total Assets 743.5m)
Interest Expense / Debt = 2.64% (Interest Expense 299.0k / Debt 11.3m)
Taxrate = 21.0% (US default 21%)
NOPAT = 22.2m (EBIT 28.0m * (1 - 21.00%))
Current Ratio = 2.37 (Total Current Assets 580.7m / Total Current Liabilities 244.9m)
Debt / Equity = 0.02 (Debt 11.3m / totalStockholderEquity, last quarter 466.8m)
Debt / EBITDA = -13.52 (Net Debt -460.3m / EBITDA 34.0m)
Debt / FCF = -5.53 (Net Debt -460.3m / FCF TTM 83.2m)
Total Stockholder Equity = 384.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.33% (Net Income 1.97m / Total Assets 743.5m)
RoE = 0.51% (Net Income TTM 1.97m / Total Stockholder Equity 384.7m)
RoCE = 7.08% (EBIT 28.0m / Capital Employed (Equity 384.7m + L.T.Debt 11.3m))
RoIC = 5.76% (NOPAT 22.2m / Invested Capital 384.7m)
WACC = 10.00% (E(2.51b)/V(2.52b) * Re(10.04%) + D(11.3m)/V(2.52b) * Rd(2.64%) * (1-Tc(0.21)))
Discount Rate = 10.04% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 13.04%
[DCF Debug] Terminal Value 75.03% ; FCFF base≈79.2m ; Y1≈97.7m ; Y5≈166.3m
Fair Price DCF = 11.37 (EV 1.99b - Net Debt -460.3m = Equity 2.45b / Shares 215.8m; r=10.00% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 44.77 | EPS CAGR: 18.59% | SUE: -1.77 | # QB: 0
Revenue Correlation: 98.16 | Revenue CAGR: 20.91% | SUE: 0.15 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.08 | Chg30d=+0.001 | Revisions Net=+2 | Analysts=10
EPS next Year (2026-12-31): EPS=0.39 | Chg30d=+0.002 | Revisions Net=+3 | Growth EPS=+16.2% | Growth Revenue=+18.1%